Anita Brikman/thefemword.world
Jul 21, 2026, 00:55
Anita Brikman on PPTA’s First-Half 2026 Achievements
Plasma Protein Therapeutics Association (PPTA) shared on LinkedIn:
”As 2026 reaches its midpoint, PPTA and its members have made significant progress in strengthening patient access to plasma-derived therapies worldwide.
From advancing advocacy efforts in North America and Europe to expanding global stakeholder engagement and supporting important regulatory initiatives, the first half of the year has demonstrated the power of collaboration across the plasma community.
Watch as PPTA President and CEO Anita Brikman reflects on key achievements from the first six months of 2026, then read the full report.”
Proceed to the video attached to the post.
Stay updated with Hemostasis Today.
-
Sep 5, 2026, 02:28N. Mariana S. Vasquez: Warm vs Cold Autoimmune Hemolytic Anemia for USMLE/NBME Questions
-
Sep 4, 2026, 22:03Maeve Crowley: Haemophilia Treatment Over the Decades and Hope for the Future
-
Sep 4, 2026, 22:01Lama Skieker: Understanding Thrombocytopenia in Malaria
-
Sep 4, 2026, 22:00Hiten Patel: How an IVC Filter Helps Prevent Pulmonary Embolism
-
Sep 4, 2026, 21:54Gianluca Costamagna: Investigating the Link Between Cancer and Acute Ischemic Stroke
-
Sep 4, 2026, 21:50Ben Creagh-Brown: PRAGUE-26 and HI-PEITHO Similar Benefits With Important Differences
-
Sep 4, 2026, 21:48Jin-Xiong She: Homocysteine beyond Heart Disease – The Methylation-Mobility Connection
-
Sep 4, 2026, 21:44Aravind Palraj: Anemia of Chronic Inflammation is Not Just “Iron Deficiency”
-
Sep 4, 2026, 21:41Chokri Ben Lamine: Fundamental HSCT Workshop for Hematology Fellows at HAAG 2026